Idiopathic Esophageal Ulcers in AIDS Completely Healed With Highly Active Anti-Retroviral Therapy
نویسندگان
چکیده
A 51-year-old white man presented to the emergency department with a 3-month history of atypical chest pain, odynophagia to solids and liquids, and a 18-kg weight loss. He was febrile to 39oC and tachycardic. Physical exam was remarkable for bilateral submandibular lymphadenopathy and thrush in the posterior oropharynx. He was diagnosed with AIDS with CD4 count 146 cells/mm3 and viral load 423,000 copies/mL. Esophagogastroduodenoscopy (EGD) showed a large, deep, irregular esophageal ulcer (Figure 1). Biopsies of the ulcer margins and bases were negative for malignancy or infection. He was diagnosed with an idiopathic esophageal ulcer (IEU) secondary to AIDS. He was started on a proton pump inhibitor and highly active anti-retroviral therapy (HAART). Three weeks later, repeat EGD revealed complete resolution of the esophageal ulcer (Figure 2). More than 1 year after diagnosis, he continued to do well with a viral load of 53, CD4 count of 708, and without any recurrence of odynophagia.
منابع مشابه
بررسی پایبندی و روند درمان ضد رترو ویروسی در بیماران مرکز مشاوره بیماریهای رفتاری اصفهان طی ده سال
Background : Highly active anti-retroviral therapy (HAART) includes the use of three or more anti-retroviral drugs with proven in controlling AIDS. The aim of this study was to investigate adherence and process of anti-retroviral therapy in patients refereed to Isfahan Behavioral Consultation Center from 1999 to 2009. Methods : This study was a cross-sectional study and therapeutic process ...
متن کاملIdentifying risk factors of immune reconstitution inflammatory syndrome in AIDS patients receiving highly active anti-retroviral therapy.
Immune reconstitution inflammation syndrome typically occurs within days after patients undergo highly active anti-retroviral therapy and is a big hurdle for effective treatment of AIDS patients. In this study, we monitored immune reconstitution inflammation syndrome occurrence in 238 AIDS patients treated with highly active anti-retroviral therapy. Among them, immune reconstitution inflammatio...
متن کاملPathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.
The advent of highly active anti-retroviral therapy (HAART) has dramatically decreased the rate of AIDS-related mortality and significantly extended the life span of patients with AIDS. A variety of metabolic side effects are associated with these therapies, one of which is metabolic bone disease. A higher prevalence of osteopenia and osteoporosis in HIV-infected patients receiving anti-retrovi...
متن کاملDevelopment of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Background The FDA approved drug Efavirenz is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) successful first line drug of choice in Highly Active Anti-Retroviral Therapy (HAART) for treatment of HIV and AIDS. It is poorly water soluble drug (10 g/ml) with 40-45% of bioavailability and administered as high doses 600-800 mg/day. Increase in solubility can enhance bioavailability; provi...
متن کاملResponse to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy
BACKGROUND AND OBJECTIVES Streptococcus pneumoniae continues to cause serious infections in HIV-positive individuals in the era of highly active anti-retroviral therapy. This led to the recommendation to revaccinate HIV-positive individuals with PPV23 five years after primary vaccination. The benefits of revaccination and the impact of long term highly active anti-retroviral therapy (HAART) on ...
متن کامل